The past year for Cyclopharm (ASX:CYC) investors has not been profitable

Investors can benefit from a rising market by buying an index fund. Active investors aim to outperform the market but risk under-performance. Cyclopharm Limited (ASX:CYC) shareholders faced a 48% share price decline in the last year, with revenue falling by 19%.